Skip to content
Preprint · OA via OpenAlex

Stem cell therapy for acute myocardial infarction: Mesenchymal Stem Cells and induced Pluripotent Stem Cells

Diana Clavellina, Wayne Balkan, Joshua M. Hare

Expert Opinion on Biological Therapy · 2023 · ▲ 40 citations

Abstract

INTRODUCTION: Acute myocardial infarction (AMI) remains a leading cause of death in the United States. The limited capacity of cardiomyocytes to regenerate and the restricted contractility of scar tissue after AMI are not addressed by current pharmacologic interventions. Mesenchymal stem/stromal cells (MSCs) have emerged as a promising therapeutic approach due to their low antigenicity, ease of harvesting, and efficacy and safety in preclinical and clinical studies, despite their low survival and engraftment rates. Other stem cell types, such as induced pluripotent stem cells (iPSCs) also show promise, and optimizing cardiac repair requires integrating emerging technologies and strategies. AREAS COVERED: This review offers insights into advancing cell-based therapies for AMI, emphasizing meticulously planned trials with a standardized definition of AMI, for a bench-to-bedside approach. We critically evaluate fundamental studies and clinical trials to provide a comprehensive overview of the advances, limitations and prospects for cell-based therapy in AMI. EXPERT OPINION: MSCs continue to show potential promise for treating AMI and its sequelae, but addressing their low survival and engraftment rates is crucial for clinical success. Integrating emerging technologies such as pluripotent stem cells and conducting well-designed trials will harness the full potential of cell-based therapy in AMI management. Collaborative efforts are vital to developing effective stem cell therapies for AMI patients.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1080/14712598.2023.2245329
Canonical
link ↗
Fetched
2026-11-08 MST

Cite this

APA
Clavellina, D., Balkan, W., &amp; Hare, J.M. (2023). Stem cell therapy for acute myocardial infarction: Mesenchymal Stem Cells and induced Pluripotent Stem Cells. <em>Expert Opinion on Biological Therapy</em>. https://doi.org/10.1080/14712598.2023.2245329
Vancouver
Clavellina D, Balkan W, Hare JM. Stem cell therapy for acute myocardial infarction: Mesenchymal Stem Cells and induced Pluripotent Stem Cells. Expert Opinion on Biological Therapy. 2023. doi:10.1080/14712598.2023.2245329.
BibTeX
@unpublished{diana2023Stemce, title = {Stem cell therapy for acute myocardial infarction: Mesenchymal Stem Cells and induced Pluripotent Stem Cells}, author = {Diana Clavellina and Wayne Balkan and Joshua M. Hare}, journal = {Expert Opinion on Biological Therapy}, year = {2023}, doi = {10.1080/14712598.2023.2245329}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings